Literature DB >> 10374247

Effects of qing fei tang (TJ-90) on aspiration pneumonia in mice.

K Iwasaki1, Q Wang, N Satoh, S Yoshida, T Akaike, K Sekizawa, H Maeda, H Sasaki.   

Abstract

The effects of Qing Fei Tang (Sei-hai To in Japanese), a Chinese traditional medical mixture, on aspiration pneumonia were studied using mice inoculated with both Streptococcus pneumoniae and gastric juice as aspiration pneumoniae models. Daily (4 weeks) oral usage of Qing Fei Tang before inoculation reduced remarkably the mortality rate of mice. In this aspiration pneumonia model, xanthine oxidase (XO) activity in the lung tissues was elevated, but this elevation was remarkably decreased by use of Qing Fei Tang. These results suggest that Qing Fei Tang pretreatment can reduce oxygen radical production in inflammed lungs and may reduce the mortality for aspiration pneumonia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374247     DOI: 10.1016/S0944-7113(99)80042-7

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  3 in total

1.  Aspiration pneumonia and bronchopneumonia in progressive supranuclear palsy treated with qing fei tang: two case reports.

Authors:  Ichiro Nozaki; Yuko Kato-Motozaki; Tokuhei Ikeda; Kazuya Takahashi; Atsuro Tagami; Chiho Ishida; Kiyonobu Komai
Journal:  J Med Case Rep       Date:  2015-03-26

2.  Seihai-to (TJ-90)-Induced Activation of Airway Ciliary Beatings of Mice: Ca2+ Modulation of cAMP-Stimulated Ciliary Beatings via PDE1.

Authors:  Haruka Kogiso; Yukiko Ikeuchi; Masako Sumiya; Shigekuni Hosogi; Saori Tanaka; Chikao Shimamoto; Toshio Inui; Yoshinori Marunaka; Takashi Nakahari
Journal:  Int J Mol Sci       Date:  2018-02-26       Impact factor: 5.923

3.  Conventional Western Treatment Combined With Chinese Herbal Medicine Alleviates the Progressive Risk of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.

Authors:  Tsai-Hui Lin; Shu-I Chen; Yuan-Chih Su; Mei-Chen Lin; Hung-Jen Lin; Sheng-Teng Huang
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.